Among those seeking obesity treatment, 1.4% to 9% meet DSM criteria for BED (Allison et al., 2007
Food and Drug Administration (FDA) indications to match
Phase 3 evaluation through VESPER 6
The peptide also demonstrates protective effects against haloperidol-induced sphincter dysfunction and oxidative stress in both sphincter tissue and brain regions
Less commonly, headaches or changes in taste perception may occur
most patients communicate through the portal Treatments Offered Weekly GLP-1 injections: compounded semaglutide, Ozempic, Wegovy, compounded tirzepatide, Mounjaro, Zepbound Oral alternative: My Custom Weight Loss Kit (metformin, bupropion, naltrexone, inositol, vitamins B6 and B12) Bottom Line Eden Health keeps semaglutide access simple with predictable monthly costs and built-in coaching, ideal if you want clinical care plus support without paying extra